5-24-20 On 24 April NIH informed the nonprofit EcoHealth Alliance led by wildlife disease specialist Peter Daszak that it was ending a grant, first awarded in 2014 and renewed in 2019, because it no longer aligned with the agency’s priorities. The move came after Conservative U.S. politicians and media suggested—without evidence—that the coronavirus causing the pandemic escaped from a laboratory in Wuhan, China, that employs a Chinese virologist who had received funding from the grant. The termination also came 1 week after President Donald Trump, when asked about the project at a press conference, said: “We will end that grant very quickly.”2 Thirty-one scientific societies have also written to Collins, calling on NIH “to be transparent about their decision-making process"
https://globalbiodefense.com/2020/05/24/thousands-of-scientists-denounce-political-federal-funding-cuts-
.......................................
3-2-20 The possible bioweapon was originally labeled 2019-nCoV. Then the UN’s World Health Organization changed the formal name to COVID-19. Is the World Health Organization a PR adjunct of Big Pharma? How tight is the relationship between the WHO and the Chinese Communist Party?
In an era of proliferating genetic engineering, how are governments and their Big Pharma partners dividing up the field of microbiology? How are they handling the divide between initiatives done in the name of public health and initiatives done to produce biological weapons for national governments including those of the United States, China, and Israel? How are the partners handling the apportionment of new wealth derived from securing patents?
These issues are finding expressions in the many legitimate questions that are coming to light in the course of the Novel Coronavirus emergency. Some of these questions arise because of a history of largely unexplained relations between the Wuhan National Biosafety Laboratory and the National Microbiology Laboratory in Winnipeg, Manitoba Canada (NML). It has been well reported that both institutions share the same top-level 4 certification assigned to containment facilities in research labs where staff can pursue high-level studies of the most dangerous pathogens known to humankind.
Built with French assistance between 2015 and 2017, the Wuhan facility at ground zero of the current epidemic is one of the premier pathogen research facilities in a country that is thought by some to be developing significant capacities for biological warfare. Similarly, the federal research facility in Winnipeg may well have an attending or indirect role in military research to advance capacities for biological warfare in collaboration with Canada’s two main allies, Israel and the United States.
Immunologist and Medical Doctor, Xiangguo Qiu, is the principal professional link at the nexus of relations between the Wuhan and Winnipeg facilities. Until recently Dr. Qiu was the head of the Vaccine Development and Antiviral Therapies Section of the Special Pathogens Programme of the NML. The NML in Winnipeg is administered by Canada’s federal Public Health Agency.
Dr. Qiu received her medical degree in China. In 1996 she moved from the Taijin area of China to the United States while already being subsidized as participant in China’s Thousand Talents Program. She soon moved to Canada from the US continuing her graduate work at the University of Manitoba. Dr. Qiu continued her professional life in both Canada and China, apparently visiting the Wuhan Biosafety Laboratory of the Chinese Academy of Science at least five times, each for two-week periods in 2017 and 2018. In each case an undisclosed Chinese entity paid her travel expenses.
After 2006 Dr. Qiu’s research specialty became the study of a variety of Ebola wild strains. The most virulent of these strains has an 80% death rate for those that contract the virus. An outbreak of Ebola from 2013 to 2016 took the lives of over 11,000 people in West Africa. Along with Dr. Gary Kobinger, Dr. Qui was said to be instrumental in developing the ZMapp treatment for Ebola using a cocktail of antibodies. In 2018 the duo received an Innovation Award from the Governor General of Canada for developing treatments for those infected with Ebola virus.
In March of 2019, Dr. Qiu and her research team sent off to China via Air Canada a package of deadly virus strains said to include Ebola and Nipah organisms. The shipment is said to have triggered an unexplained negative response from officials in China. The flagged problem probably involved an alleged failure to follow proper procedures in the transfer of materials that can be used for the manufacturing of bioweapons as well as in the making of vaccines to prevent the spread of infection.
The episode led to the decision of Canada’s Public Health Agency to call in the Royal Canadian Mounted Police (RCMP) to investigate. This investigation was directed at Dr. Qiu and her husband, Cheng Keding, who is also an acknowledged expert in the field of virology.
As a result of these developments an episode occurred that was reported on July 14 by the Canadian Broadcasting Corporation, CBC. In her CBC article, Karen Pauls reported, A researcher with ties to China was recently escorted out of the National Microbiology Lab (NML) in Winnipeg amid an RCMP investigation into what's being described as a possible "policy breach.” Dr. Xiangguo Qiu, her husband Keding Cheng and an unknown number of her students from China were removed from Canada's only level-4 lab on July 5.
The CBC acted pretty much as a stenographer of official sources whose clear mission was to keep a lid on the potentially explosive story. The story would become even more explosive with the inception in December of 2019 of the Coronavirus crisis in China. Rather than trying to go around the official platitudes by engaging in some independent sleuthing known as investigative journalism, CBC did what most mainstream venues do these days. CBC acted as a xerox machine to relay the tepid pronouncements of a timid and ill-guided bureaucracy.
Paul cited, for instance, an official in Canada’s Public Health Agency referring to the removal of Dr. Qiu, her husband and her research team as an “administrative matter” that will be “resolved expeditiously.” Several officials including a RCMP spokesman, indicated, “There is no threat to public safety at this time.”
A federal media relations officer continued the effort of deflection by trying to make a really unusual, complex and many-faceted story seem unremarkable. The commentator affirmed, “the work of the NML continues in support of the health and safety of all Canadians.” Leah West, an International Affairs Professor at Carlton University of Ottawa, went as far as venturing that “national security” issues might be involved. This statement calls for explanations that Canadian reporters have so far not seriously attempted.
Lt. Colonel Dr. Dany Shoham is one of the most attentive figures outside Canada who responded especially quickly and skeptically to the perplexing questions raised by Dr. Qiu’s activities. Dr. Shoham is a reserve member of the IDF. He continues his military responsibilities in the fields of biological and chemical warfare as a senior researcher in the Begin-Sadat Center for Strategic Studies in Israel.
In 2014 Dr. Shoham was a visiting scholar at the New Delhi-based Institute for Defence Studies and Analysis (IDSA). There he collaborated professionally with the IDSA’s Deputy Director, Brigadier Rumel Dahiya. Dr. Shoham devoted much of his time in India to studying what he refers to as China’s Biological Warfare Programme.
Dr. Shoham published his findings in 2015 in an “integrative study” where he commented at significant length on the makeup and structure of China’s secretive military R and D initiatives in the alleged development of bioweapons. He maintains that these secretive military operations have been blended into the operations of “ostensibly civilian facilities” where public health initiatives in disease prevention and treatment are often highlighted
Dr. Shoham notes that the government of China became a signatory in 1984 to UN’s Biological Weapons Convention of 1972. The Israeli academic alleges, however, that China, a target of US biological war in the Korean War in the early 1950s, opted to secretly retain some continuing capacities in this military field. Dr. Shoham has cast himself as an insistent whistle blower calling attention to the provocative circumstances attending the shipment from Canada to China of virulent pathogens. Dr. Shoham indicated that Dr. Qiu’s research has been conducted not only on behalf of the governments of Canada and China. Dr. Qui has also collaborated with three scientists from the US Army Medical Research Institute of Infectious Diseases in Maryland. Much of her success, however, is connected to her obtaining many grants from China, all on the “national level.”
In the July-December 2019 issue of the IDSA Journal, Dr. Shoman explained. But the collateral Chinese plexus cannot be ignored. Married to a Chinese scientist – Dr. Keding Cheng, also affiliated with the NML (specifically the “Science and Technology Core”), and primarily a bacteriologist who shifted to virology – Dr. Qiu frequently visited and maintained tight bonds with China, generally speaking, and many Chinese students joined her works in the NML during the recent decade, coming from a notable range of Chinese scientific facilities. Nonetheless, among the latter there are four facilities that have been regarded to possess parts of the Chinese biological weapons alignment, namely -Institute of Military Veterinary, Academy of Military Medical Sciences, Changchun. -Center for Disease Control and Prevention, Chengdu Military Region. -Wuhan Institute of Virology, Chinese Academy of Sciences, Hubei. -Institute of Microbiology, Chinese Academy of Sciences, Beijing.
All of the four mentioned facilities collaborated with Dr. Qiu within the context of Ebola virus, yet the Institute of Military Veterinary joined a study on the Rift Valley fever virus, while the Institute of Microbiology joined a study on Marburg virus too. Noticeably, the drug used in the latter study – Favipiravir – has been earlier tested successfully by the Chinese Academy of Military Medical Sciences, with the designation JK-05 (originally a Japanese patent registered in China already in 2006), against Ebola and additional viruses.
However, the studies by Dr. Qiu are considerably more advanced and fruitful, in certain aspects. They are apparently vital for the Chinese biological weapons developing, in case Ebola, Nipah, Marburg or Rift Valley fever viruses are included therein, which is a plausible postulation; let alone the wild type viruses in themselves. And it is of note that only Nipah virus is naturally found in China or neighboring countries. Collectively, then, the interface between Dr. Qiu and China has a priori been highly suspicious. On top of it, the shipment of the two viruses from NML to China apparently generated an alarm, beyond its seeming inappropriateness. And an unavoidable question is whether previous shipments to China of other viruses or other essential preparations, took place from 2006 to 2018, one way or another.
https://webcache.googleusercontent.com/search?q=cache:CtFC-nKq7k8J:https://ahtribune.com/world/3930-who-or-what-started-the-wuhan-coronavirus.html%3Ffbclid%3DIwAR0H1jCG-ZnR5jrfVF9Czk01Cby2_pZCA2w1YL69dhi24foJnxod2aoiXmY+&cd=7&hl=en&ct=clnk&gl=us&client=safari
.......................................
3-2-20 The possible bioweapon was originally labeled 2019-nCoV. Then the UN’s World Health Organization changed the formal name to COVID-19. Is the World Health Organization a PR adjunct of Big Pharma? How tight is the relationship between the WHO and the Chinese Communist Party?
In an era of proliferating genetic engineering, how are governments and their Big Pharma partners dividing up the field of microbiology? How are they handling the divide between initiatives done in the name of public health and initiatives done to produce biological weapons for national governments including those of the United States, China, and Israel? How are the partners handling the apportionment of new wealth derived from securing patents?
These issues are finding expressions in the many legitimate questions that are coming to light in the course of the Novel Coronavirus emergency. Some of these questions arise because of a history of largely unexplained relations between the Wuhan National Biosafety Laboratory and the National Microbiology Laboratory in Winnipeg, Manitoba Canada (NML). It has been well reported that both institutions share the same top-level 4 certification assigned to containment facilities in research labs where staff can pursue high-level studies of the most dangerous pathogens known to humankind.
Built with French assistance between 2015 and 2017, the Wuhan facility at ground zero of the current epidemic is one of the premier pathogen research facilities in a country that is thought by some to be developing significant capacities for biological warfare. Similarly, the federal research facility in Winnipeg may well have an attending or indirect role in military research to advance capacities for biological warfare in collaboration with Canada’s two main allies, Israel and the United States.
Immunologist and Medical Doctor, Xiangguo Qiu, is the principal professional link at the nexus of relations between the Wuhan and Winnipeg facilities. Until recently Dr. Qiu was the head of the Vaccine Development and Antiviral Therapies Section of the Special Pathogens Programme of the NML. The NML in Winnipeg is administered by Canada’s federal Public Health Agency.
Dr. Qiu received her medical degree in China. In 1996 she moved from the Taijin area of China to the United States while already being subsidized as participant in China’s Thousand Talents Program. She soon moved to Canada from the US continuing her graduate work at the University of Manitoba. Dr. Qiu continued her professional life in both Canada and China, apparently visiting the Wuhan Biosafety Laboratory of the Chinese Academy of Science at least five times, each for two-week periods in 2017 and 2018. In each case an undisclosed Chinese entity paid her travel expenses.
After 2006 Dr. Qiu’s research specialty became the study of a variety of Ebola wild strains. The most virulent of these strains has an 80% death rate for those that contract the virus. An outbreak of Ebola from 2013 to 2016 took the lives of over 11,000 people in West Africa. Along with Dr. Gary Kobinger, Dr. Qui was said to be instrumental in developing the ZMapp treatment for Ebola using a cocktail of antibodies. In 2018 the duo received an Innovation Award from the Governor General of Canada for developing treatments for those infected with Ebola virus.
In March of 2019, Dr. Qiu and her research team sent off to China via Air Canada a package of deadly virus strains said to include Ebola and Nipah organisms. The shipment is said to have triggered an unexplained negative response from officials in China. The flagged problem probably involved an alleged failure to follow proper procedures in the transfer of materials that can be used for the manufacturing of bioweapons as well as in the making of vaccines to prevent the spread of infection.
The episode led to the decision of Canada’s Public Health Agency to call in the Royal Canadian Mounted Police (RCMP) to investigate. This investigation was directed at Dr. Qiu and her husband, Cheng Keding, who is also an acknowledged expert in the field of virology.
As a result of these developments an episode occurred that was reported on July 14 by the Canadian Broadcasting Corporation, CBC. In her CBC article, Karen Pauls reported, A researcher with ties to China was recently escorted out of the National Microbiology Lab (NML) in Winnipeg amid an RCMP investigation into what's being described as a possible "policy breach.” Dr. Xiangguo Qiu, her husband Keding Cheng and an unknown number of her students from China were removed from Canada's only level-4 lab on July 5.
The CBC acted pretty much as a stenographer of official sources whose clear mission was to keep a lid on the potentially explosive story. The story would become even more explosive with the inception in December of 2019 of the Coronavirus crisis in China. Rather than trying to go around the official platitudes by engaging in some independent sleuthing known as investigative journalism, CBC did what most mainstream venues do these days. CBC acted as a xerox machine to relay the tepid pronouncements of a timid and ill-guided bureaucracy.
Paul cited, for instance, an official in Canada’s Public Health Agency referring to the removal of Dr. Qiu, her husband and her research team as an “administrative matter” that will be “resolved expeditiously.” Several officials including a RCMP spokesman, indicated, “There is no threat to public safety at this time.”
A federal media relations officer continued the effort of deflection by trying to make a really unusual, complex and many-faceted story seem unremarkable. The commentator affirmed, “the work of the NML continues in support of the health and safety of all Canadians.” Leah West, an International Affairs Professor at Carlton University of Ottawa, went as far as venturing that “national security” issues might be involved. This statement calls for explanations that Canadian reporters have so far not seriously attempted.
Lt. Colonel Dr. Dany Shoham is one of the most attentive figures outside Canada who responded especially quickly and skeptically to the perplexing questions raised by Dr. Qiu’s activities. Dr. Shoham is a reserve member of the IDF. He continues his military responsibilities in the fields of biological and chemical warfare as a senior researcher in the Begin-Sadat Center for Strategic Studies in Israel.
In 2014 Dr. Shoham was a visiting scholar at the New Delhi-based Institute for Defence Studies and Analysis (IDSA). There he collaborated professionally with the IDSA’s Deputy Director, Brigadier Rumel Dahiya. Dr. Shoham devoted much of his time in India to studying what he refers to as China’s Biological Warfare Programme.
Dr. Shoham published his findings in 2015 in an “integrative study” where he commented at significant length on the makeup and structure of China’s secretive military R and D initiatives in the alleged development of bioweapons. He maintains that these secretive military operations have been blended into the operations of “ostensibly civilian facilities” where public health initiatives in disease prevention and treatment are often highlighted
Dr. Shoham notes that the government of China became a signatory in 1984 to UN’s Biological Weapons Convention of 1972. The Israeli academic alleges, however, that China, a target of US biological war in the Korean War in the early 1950s, opted to secretly retain some continuing capacities in this military field. Dr. Shoham has cast himself as an insistent whistle blower calling attention to the provocative circumstances attending the shipment from Canada to China of virulent pathogens. Dr. Shoham indicated that Dr. Qiu’s research has been conducted not only on behalf of the governments of Canada and China. Dr. Qui has also collaborated with three scientists from the US Army Medical Research Institute of Infectious Diseases in Maryland. Much of her success, however, is connected to her obtaining many grants from China, all on the “national level.”
In the July-December 2019 issue of the IDSA Journal, Dr. Shoman explained. But the collateral Chinese plexus cannot be ignored. Married to a Chinese scientist – Dr. Keding Cheng, also affiliated with the NML (specifically the “Science and Technology Core”), and primarily a bacteriologist who shifted to virology – Dr. Qiu frequently visited and maintained tight bonds with China, generally speaking, and many Chinese students joined her works in the NML during the recent decade, coming from a notable range of Chinese scientific facilities. Nonetheless, among the latter there are four facilities that have been regarded to possess parts of the Chinese biological weapons alignment, namely -Institute of Military Veterinary, Academy of Military Medical Sciences, Changchun. -Center for Disease Control and Prevention, Chengdu Military Region. -Wuhan Institute of Virology, Chinese Academy of Sciences, Hubei. -Institute of Microbiology, Chinese Academy of Sciences, Beijing.
All of the four mentioned facilities collaborated with Dr. Qiu within the context of Ebola virus, yet the Institute of Military Veterinary joined a study on the Rift Valley fever virus, while the Institute of Microbiology joined a study on Marburg virus too. Noticeably, the drug used in the latter study – Favipiravir – has been earlier tested successfully by the Chinese Academy of Military Medical Sciences, with the designation JK-05 (originally a Japanese patent registered in China already in 2006), against Ebola and additional viruses.
However, the studies by Dr. Qiu are considerably more advanced and fruitful, in certain aspects. They are apparently vital for the Chinese biological weapons developing, in case Ebola, Nipah, Marburg or Rift Valley fever viruses are included therein, which is a plausible postulation; let alone the wild type viruses in themselves. And it is of note that only Nipah virus is naturally found in China or neighboring countries. Collectively, then, the interface between Dr. Qiu and China has a priori been highly suspicious. On top of it, the shipment of the two viruses from NML to China apparently generated an alarm, beyond its seeming inappropriateness. And an unavoidable question is whether previous shipments to China of other viruses or other essential preparations, took place from 2006 to 2018, one way or another.
https://webcache.googleusercontent.com/search?q=cache:CtFC-nKq7k8J:https://ahtribune.com/world/3930-who-or-what-started-the-wuhan-coronavirus.html%3Ffbclid%3DIwAR0H1jCG-ZnR5jrfVF9Czk01Cby2_pZCA2w1YL69dhi24foJnxod2aoiXmY+&cd=7&hl=en&ct=clnk&gl=us&client=safari
No comments:
Post a Comment